172 related articles for article (PubMed ID: 37047835)
1. Doxorubicin-Mediated miR-433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR-Independent Manner.
Vulpis E; Cuollo L; Borrelli C; Antonangeli F; Masuelli L; Cippitelli M; Fionda C; Caracciolo G; Petrucci MT; Santoni A; Zingoni A; Soriani A
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047835
[TBL] [Abstract][Full Text] [Related]
2. Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15
Borrelli C; Ricci B; Vulpis E; Fionda C; Ricciardi MR; Petrucci MT; Masuelli L; Peri A; Cippitelli M; Zingoni A; Santoni A; Soriani A
Cancer Immunol Res; 2018 Jul; 6(7):860-869. PubMed ID: 29691234
[TBL] [Abstract][Full Text] [Related]
3. Insight into the role of PIKK family members and NF-кB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells.
Strzeszewska A; Alster O; Mosieniak G; Ciolko A; Sikora E
Cell Death Dis; 2018 Jan; 9(2):44. PubMed ID: 29352261
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
[TBL] [Abstract][Full Text] [Related]
6. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.
Soriani A; Zingoni A; Cerboni C; Iannitto ML; Ricciardi MR; Di Gialleonardo V; Cippitelli M; Fionda C; Petrucci MT; Guarini A; Foà R; Santoni A
Blood; 2009 Apr; 113(15):3503-11. PubMed ID: 19098271
[TBL] [Abstract][Full Text] [Related]
7. A chemotherapy-associated senescence bystander effect in breast cancer cells.
Di X; Bright AT; Bellott R; Gaskins E; Robert J; Holt S; Gewirtz D; Elmore L
Cancer Biol Ther; 2008 Jun; 7(6):864-72. PubMed ID: 18340112
[TBL] [Abstract][Full Text] [Related]
8. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
9. The p53/miRNAs/Ccna2 pathway serves as a novel regulator of cellular senescence: Complement of the canonical p53/p21 pathway.
Xu S; Wu W; Huang H; Huang R; Xie L; Su A; Liu S; Zheng R; Yuan Y; Zheng HL; Sun X; Xiong XD; Liu X
Aging Cell; 2019 Jun; 18(3):e12918. PubMed ID: 30848072
[TBL] [Abstract][Full Text] [Related]
10. miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways.
Shang J; Yao Y; Fan X; Shangguan L; Li J; Liu H; Zhou Y
Biochim Biophys Acta; 2016 Apr; 1863(4):520-32. PubMed ID: 26792405
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the P53/P21 Pathway Attenuates the Effects of Senescent Nucleus Pulposus Cell-Derived Exosomes on the Senescence of Nucleus Pulposus Cells.
Chen CC; Chen J; Wang WL; Xie L; Shao CQ; Zhang YX
Orthop Surg; 2021 Apr; 13(2):583-591. PubMed ID: 33314719
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
13. miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding.
Peng D; Wang H; Li L; Ma X; Chen Y; Zhou H; Luo Y; Xiao Y; Liu L
Leukemia; 2018 May; 32(5):1180-1188. PubMed ID: 29479064
[TBL] [Abstract][Full Text] [Related]
14. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
15. PTTG1 attenuates drug-induced cellular senescence.
Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
[TBL] [Abstract][Full Text] [Related]
16. Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells.
Yang MY; Lin PM; Liu YC; Hsiao HH; Yang WC; Hsu JF; Hsu CM; Lin SF
PLoS One; 2012; 7(5):e37205. PubMed ID: 22606351
[TBL] [Abstract][Full Text] [Related]
17. The PPARγ-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence.
Shih CT; Chang YF; Chen YT; Ma CP; Chen HW; Yang CC; Lu JC; Tsai YS; Chen HC; Tan BC
Aging Cell; 2017 Aug; 16(4):797-813. PubMed ID: 28514051
[TBL] [Abstract][Full Text] [Related]
18. BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells.
Su D; Zhu S; Han X; Feng Y; Huang H; Ren G; Pan L; Zhang Y; Lu J; Huang B
J Biol Chem; 2009 May; 284(18):12153-64. PubMed ID: 19269967
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence.
Marino Gammazza A; Campanella C; Barone R; Caruso Bavisotto C; Gorska M; Wozniak M; Carini F; Cappello F; D'Anneo A; Lauricella M; Zummo G; Conway de Macario E; Macario AJ; Di Felice V
Cancer Lett; 2017 Jan; 385():75-86. PubMed ID: 27836734
[TBL] [Abstract][Full Text] [Related]
20. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
